Myocardial Infarction
📧 Sign up to get email alerts when something new happens for Myocardial Infarction.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2021-08-17FDA Approved: LISINOPRIL — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved a supplemental application for lisinopril from Camber Pharmaceuticals, Inc., for the generic product.
-
FDA approval · 2021-08-05FDA Approved: ENALAPRIL MALEATE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a supplemental application for enalaprilate maleate from Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc., effecti…
-
FDA approval · 2021-07-09FDA Approved: TICAGRELOR — Original Application (Mylan Pharmaceuticals Inc.)
FDA approves Mylan's generic ticagrelor under ANDA 208597.
-
CLINICAL_TRIALS trial_result · 2021-07-07Clinical Trial Update: Effect of Shexiang Tongxin Dropping Pills on Microcirculation in Patients With AMI [Phase 4]
Phase 4 clinical trial update studying the effect of Shexiang Tongxin Dropping Pills on microcirculation in patients with acute myocardial i…
-
CLINICAL_TRIALS trial_result · 2021-06-25Clinical Trial Update: Disrupt CAD IV With the Shockwave Coronary IVL System [NA]
Clinical trial update for the Shockwave Coronary IVL System (Disrupt CAD IV) showing completed study with posted results.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-06-21Clinical Trial Update: Disrupt CAD III With the Shockwave Coronary IVL System [NA]
Completed clinical trial of the Shockwave Coronary IVL System (Disrupt CAD III) with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-06-04Clinical Trial Update: MBCT Delivered Via Group Videoconferencing for ACS Patients With Elevated Depression Symptoms [NA]
Clinical trial update on mindfulness-based cognitive therapy delivered via group videoconferencing for ACS patients with elevated depression…
-
FDA approval · 2021-05-28FDA Approved: BIVALIRUDIN — Original Application (Slate Run Pharmaceuticals, LLC)
FDA approved the original application for a generic Bivalirudin product from Slate Run Pharmaceuticals, LLC.
-
CLINICAL_TRIALS trial_result · 2021-05-27Clinical Trial Update: Study of Dutogliptin in Combination With Filgrastim in Post-Myocardial Infarction [Phase 2]
A Phase 2 study evaluating dutogliptin in combination with filgrastim for patients after acute myocardial infarction has completed.
-
CLINICAL_TRIALS trial_result · 2021-05-07Clinical Trial Update: CRUSHed vs. Uncrushed Prasugrel in STEMI Patients Undergoing PCI [Phase 4]
A Phase 4 trial comparing crushed versus uncrushed prasugrel in STEMI patients undergoing PCI has completed.
-
CLINICAL_TRIALS trial_result · 2021-04-30Clinical Trial Update: Dual Therapy With Dabigatran/Ticagrelor Versus Dual Therapy With Dabigatran/Clopidogrel in ACS Patients With Indication for NOAC Undergoing PCI [Phase 4]
A Phase 4 trial comparing dual therapy with dabigatran and ticagrelor versus dabigatran and clopidogrel in ACS patients needing NOAC undergo…
-
CLINICAL_TRIALS trial_result · 2021-04-20Clinical Trial Update: Shortened Aggrastat® Versus Integrilin in Percutaneous Coronary Intervention [Phase 2]
Phase 2 trial comparing shortened Aggrastat to Integrilin in percutaneous coronary intervention has completed with results posted.
-
FDA approval · 2021-04-14FDA Approved: BIVALIRUDIN — Supplemental Application (Fresenius Kabi USA, LLC)
The FDA approved a supplemental application for the generic anticoagulant Bivalirudin from Fresenius Kabi USA, LLC.
-
CLINICAL_TRIALS trial_result · 2021-04-13Clinical Trial Update: BAMI. The Effect of Intracoronary Reinfusion of Bone Marrow-derived Mononuclear Cells(BM-MNC) on All Cause Mortality in Acute Myocardial Infarction [Phase 3]
Phase 3 trial evaluating intracoronary reinfusion of bone marrow-derived mononuclear cells after acute myocardial infarction; completed stud…
-
CLINICAL_TRIALS trial_result · 2021-04-09Clinical Trial Update: Cardiovascular Clinical Project to Evaluate the Regenerative Capacity of CardioCell in Patients With Acute Myocardial Infarction (AMI) [Phase 2, Phase 3]
A phase 2/3 clinical trial evaluating the regenerative capacity of CardioCell in patients with acute myocardial infarction has been complete…
-
FDA approval · 2021-04-02FDA Approved: RAMIPRIL — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approved Lupin Pharmaceuticals' supplemental application for ramipril (generic ACE inhibitor), enabling continued marketing with the…
-
FDA approval · 2021-04-02FDA Approved: RAMIPRIL — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for Ramipril from Rising Pharma Holdings, Inc., indicating an updated approval under the ANDA.
-
CLINICAL_TRIALS trial_result · 2021-04-02Clinical Trial Update: TicAgrelor Versus CLOpidogrel in Stabilized Patients With Acute Myocardial Infarction: TALOS-AMI [Phase 4]
Phase 4 trial comparing TicAgrelor to Clopidogrel in stabilized acute myocardial infarction patients.
-
CLINICAL_TRIALS trial_result · 2021-03-15Clinical Trial Update: A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction. [Phase 2]
Phase 2b trial update for CSL112 in patients after acute myocardial infarction has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-03-05Clinical Trial Update: Effect of Dapagliflozin on LV Remodeling Post AMI [Phase 4]
Phase 4 clinical trial update investigating the effect of dapagliflozin on left ventricular remodeling after myocardial infarction.
-
FDA approval · 2021-03-04FDA Approved: LISINOPRIL — Original Application (Chartwell RX, LLC)
FDA approves Chartwell RX, LLC’s original application for lisinopril, a generic ACE inhibitor. Lisinopril is used to treat hypertension, con…
-
CLINICAL_TRIALS trial_result · 2021-03-02Clinical Trial Update: ASSessing the Effect of Anti-IL-6 Treatment in Myocardial Infarction: The ASSAIL-MI Trial [Phase 2]
Phase 2 trial assessing anti-IL-6 treatment in myocardial infarction has completed.
-
CLINICAL_TRIALS trial_result · 2021-02-23Clinical Trial Update: A Trial Using Double-Bolus THR-100 Versus Streptokinase [Phase 3]
Phase 3 trial comparing double-bolus THR-100 with Streptokinase in acute myocardial infarction has completed.
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: Intravenous MSC Therapy on Ischemia-Reperfusion Injury in Patients With Myocardial Infarction [Phase 1, Phase 2]
A clinical trial update on intravenous mesenchymal stem cell therapy for ischemia-reperfusion injury in patients with myocardial infarction,…
-
FDA approval · 2021-02-17FDA Approved: BRILINTA — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for Brilinta (ticagrelor) submitted by AstraZeneca Pharmaceuticals LP.